Giardiasis: comprehensive life cycle, malabsorption, diagnosis, treatment and prevention

Learning outcomes

• Describe the cyst and trophozoite forms and the excystation–encystation cycle.
• Explain how mucosal attachment produces lactase deficiency, steatorrhoea and weight loss.
• Recognise acute, persistent, asymptomatic and immunodeficiency-associated disease.
• Choose stool antigen, PCR and serial microscopy appropriately.
• Manage hydration, nutrition, antiprotozoal treatment, reinfection and persistent symptoms.
• Give practical water, food, household and sexual-transmission prevention advice.

Organism and morphology

After cyst ingestion, gastric acid triggers excystation in the duodenum. Trophozoites multiply by binary fission, attach to the duodenal/jejunal brush border and encyst during distal transit. Cysts are immediately infectious when excreted.

Transmission and risk factors

• Untreated surface water, shallow wells, streams, lakes, ice and contaminated recreational water.
• Food washed or prepared with contaminated water.
• Person-to-person spread in households, childcare centres, schools and institutions.
• Fecal–oral sexual exposure, including oral–anal contact.
• Travel, crowded housing, poor sanitation and unsafe faeces disposal.
• Hypochlorhydria, malnutrition, hypogammaglobulinaemia, HIV and other immune deficits.

Giardia is found worldwide. The most important route is swallowing human faecal contamination; cats and dogs are not the usual source of human infection, although animal-associated transmission can occur.

Pathophysiology

Trophozoites form a dense surface layer over enterocytes. Their adhesive disc and secreted products disrupt microvilli, tight junctions, brush-border enzymes and bile-salt handling. Villous shortening and epithelial inflammation impair digestion and absorption of fat, carbohydrates, folate, vitamin B12 and other nutrients. Lactase deficiency commonly causes temporary secondary lactose intolerance. Because tissue invasion and systemic bacteraemia are not typical, high fever, frank blood, peritonism or marked inflammatory toxicity should prompt another diagnosis or co-infection.

Clinical spectrum

Incubation and acute disease

Symptoms usually begin about one to two weeks after exposure. The patient may develop watery diarrhoea, cramps, bloating, nausea, fatigue, anorexia and excessive flatus. Stool is often pale, greasy, foul-smelling and difficult to flush. Mild fever can occur but high fever is unusual.

Persistent and chronic disease

Symptoms fluctuate over weeks. Steatorrhoea, weight loss, weakness, abdominal distension, lactose intolerance and micronutrient deficiency may develop. Children can have poor growth and reduced school performance. Post-infectious irritable bowel symptoms may persist after eradication.

Asymptomatic carriage

Some infected people have no symptoms yet shed cysts. A positive test should be interpreted with exposure, symptoms, outbreak context and alternative diagnoses. Public-health or household treatment decisions should follow current guidance rather than indiscriminate treatment.

Severe or unusual disease

Infants, malnourished patients, people with hypogammaglobulinaemia and patients with HIV may have prolonged diarrhoea, dehydration and wasting. Extraintestinal giardiasis is not the expected syndrome.

History and examination

Ask duration, stool character, blood/mucus, fever, vomiting, weight change, travel, camping, water source, swimming, childcare exposure, household diarrhoea, oral–anal sex, recent antibiotics and previous therapy. Ask about lactose-containing foods and immune deficiency.

Assess hydration, pulse, blood pressure, mucous membranes, postural symptoms, skin turgor, abdominal distension/tenderness, weight and growth. Look for fever, blood, peritonism, severe pain or toxicity that suggest invasive bacterial disease, amoebiasis, inflammatory bowel disease or surgical pathology.

Diagnosis

Stool testing

• Antigen detection: enzyme immunoassays and direct fluorescent antibody methods are useful where available.
• Nucleic-acid amplification/PCR: highly sensitive and can identify mixed infections, but a positive result may reflect carriage.
• Microscopy: look for cysts and trophozoites on concentration and wet preparations. Because shedding is intermittent, submit two or three specimens collected on separate days when suspicion persists.

Tests rarely required

Duodenal aspirate, biopsy or an enterotest is reserved for persistent unexplained disease after stool testing. There is no routine blood test that confirms intestinal giardiasis.

Differential diagnosis

Cholera, shigellosis, campylobacteriosis, salmonellosis, cryptosporidiosis, amoebiasis, helminths, viral gastroenteritis, HIV enteropathy, coeliac disease, pancreatic insufficiency, lactose intolerance, inflammatory bowel disease and irritable bowel syndrome.

Management

Rehydration and nutrition

• Use oral rehydration solution for ongoing losses; give IV isotonic fluid for shock, severe dehydration or inability to drink.
• Continue breastfeeding and age-appropriate feeding. Avoid prolonged fasting.
• Temporarily reduce lactose if it clearly worsens symptoms, then reintroduce gradually.
• Assess weight, electrolytes and nutrition in prolonged disease.

Persistent or refractory giardiasis: a structured approach

1. Confirm that the original test was specific and that symptoms fit giardiasis.
2. Repeat stool testing using serial specimens, antigen or PCR after treatment if symptoms persist.
3. Review the dose, timing, vomiting, interactions and completion of therapy.
4. Ask about untreated symptomatic contacts, unsafe water, childcare or sexual re-exposure.
5. Test for HIV, hypogammaglobulinaemia, coeliac disease, inflammatory bowel disease or pancreatic disease when clinically indicated.
6. Look for post-infectious lactose intolerance or IBS when tests are negative.

Routine “test of cure” in an asymptomatic patient is not generally required. Retesting is most useful when symptoms continue, reinfection is suspected or a public-health outbreak is being investigated.

Complications

• Dehydration, hypokalaemia and acute kidney injury.
• Weight loss, malnutrition and micronutrient deficiency.
• Growth faltering and impaired development in children.
• Secondary lactose intolerance and post-infectious IBS.
• Prolonged disease in hypogammaglobulinaemia or HIV.

Prevention and outbreak control

• Wash hands with soap after toileting/diaper care and before food preparation.
• Boil unsafe water for at least one minute or use a validated filter; turbid water should be settled/filtered before disinfection.
• Do not swallow swimming or recreational water; keep symptomatic children out of pools.
• Use safe water to wash raw produce, make ice and brush teeth.
• Clean/disinfect surfaces contaminated by diarrhoea and launder soiled clothing.
• Avoid oral–anal sexual contact during illness and until diarrhoea has resolved; use barriers.
• Report clusters in childcare, schools, institutions or shared water supplies.

Exam and OSCE pearls

• Giardia attaches but does not usually invade; malabsorption is the key pathophysiology.
• Greasy foul-smelling stool plus bloating and weight loss is more characteristic than fever.
• One negative stool does not exclude disease because cyst shedding is intermittent.
• Persistent lactose intolerance can mimic treatment failure.
• High fever, blood, peritonism or severe toxicity requires a broader infectious/surgical evaluation.

References

• SlideShare: Giardiasis.
• Uganda Clinical Guidelines: GI008.
• CDC: About Giardia infection.
• CDC: Giardia diagnosis and testing.
• CDC: Giardia treatment.

Safety note: Confirm diagnosis and use current UCG dosing, especially in pregnancy, infancy, liver disease and immunocompromised patients.